MindMed Archives

Psychedelics News

MindMed

Industry

20 Dec 2022

Top 5 Psychedelic Milestones of 2022

2022 was a big year for psychedelic medicine industry, we take a look at the top 5 psychedelic milestones for 2022...

By James Hallifax

Industry, Science

30 Nov 2022

New MindMed Study Shortens Trip with “LSD-Neutralizer”

MindMed collaborators published a paper showing that the administration of ketanserin, effectively ends LSD’s psychedelic experience within 2....

By James Hallifax

Finance

6 Oct 2022

Can Psychedelic Stocks Like MindMed and atai Ever Recover?

Should investors begin ringing the funeral bells for psychedelic stocks? Can psychedelic stocks Like MindMed and atai ever recover? James Hallifax takes a deeper look....

By James Hallifax

Industry

29 Sep 2022

MindMed in Trouble? Serious Problems or Retail Panic?

MindMed stock has been dropping and investors are concerned....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

20 Sep 2022

MindMed Doses First Patients in Phase 1 MDMA Trial

MindMed Collaborators Dose First Subject in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances...

By Microdose NewsDesk

Finance

14 Sep 2022

MindMed Retains its NASDAQ Listing

MindMed has received a letter from The Nasdaq Stock Market LLC advising the Company that it has regained compliance with Nasdaq's minimum bid price listing requirement....

By Microdose NewsDesk

Industry

8 Sep 2022

MindMed Faces Tough IP Questions (and Publishes Positive Trial Results)

MindMed’s been in the news as of late....

By Jason Najum

Don’t Miss

29 Aug 2022

News You Might Have Missed: Aug 29th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Finance

27 Aug 2022

MindMed Completes 1-for-15 Reverse Share Split

MindMed Completes 1-for-15 Reverse Share Split....

By Microdose NewsDesk

Follow us on social

Latest News

Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing

The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result